Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yasuyuki Katayama
Pharmacological and Clinical Profiles of New Soluble Basal Insulin Analogue, Insulin Detemir (Levemir®)
Folia Pharmacologica Japonica
Pharmacology
Related publications
Insulin Toujeo® — A Novel Basal Long-Acting Insulin Formulation. Part 2. Clinical Efficacy and Safety
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
Evaluation of Dosing and Clinical Outcomes in Patients Undergoing Conversion of Insulin Glargine to Insulin Detemir
Pharmacotherapy
Pharmacology
Recombinant DNA Derived Monomeric Insulin Analogue: Comparison With Soluble Human Insulin in Normal Subjects.
BMJ
Type III Allergy to Insulin Detemir
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Basal Supplementation of Insulin Lispro Protamine Suspension Versus Insulin Glargine and Detemir for Type 2 Diabetes: Meta-Analysis of Randomized Controlled Trials
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Clinical Benefit of Basal Insulin Analogue Treatment in Persons With Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Miscibility of Human and Bovine Ultralente Insulin With Soluble Insulin.
BMJ
Insulin Detemir Is Associated With More Predictable Glycemic Control and Reduced Risk of Hypoglycemia Than NPH Insulin in Patients With Type 1 Diabetes on a Basal-Bolus Regimen With Premeal Insulin Aspart
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Inpatient Hyperglycemia Management: The Opportunities of a New Basal Insulin
Italian Journal of Medicine
Medicine
